| Investor Type | Firm |
| Industries | BioTech • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Life Science |
NeoMed Management is an Oslo-based venture capital firm that operates within the healthcare sector, specializing in investments across the broader healthcare, pharmaceutical, medical device, and diagnostic industries.
With a focus on innovation and development within the life sciences sphere, NeoMed Management positions itself as a strategic partner in the growth and success of companies operating within BioTech, Medical Devices (& Hospital Services), Healthcare (& Wellness), and Life Science domains.
The investment strategy of the firm is geographically centered, with a predominant emphasis on opportunities in Europe and a selective approach towards investments in North America. NeoMed Management's operational philosophy revolves around identifying and nurturing companies that demonstrate high potential in developing breakthrough medical products and services with the ability to improve patient outcomes and streamline healthcare delivery.
The firm takes an active role in the progression of its portfolio companies, often engaging in board participation and offering strategic guidance to drive commercialization and market expansion. The mission of NeoMed Management is to contribute both financial and intellectual capital in the high stakes environment of healthcare innovation, thus catalyzing the growth of their portfolio companies and aiming for superior returns for their investors. The firm's investment thesis reflects a deep industry insight and a commitment to supporting the next wave of healthcare solutions that can effectively address the evolving demands of both patients and providers in the global healthcare ecosystem.









